🌍 Society & Frontier mixed · 3–10 years
A what‑if from the future

What if Healthy-aging gains push effective retirement ages higher?

Rising healthspan lets people work productively into their late 60s and 70s, expanding effective labor supply and softening the fiscal and growth impact of population aging.

34%
our model probability
over 3–10 years
prediction markets — wisdom of the crowd
loading live odds…
Empirically anchored 34% · 90% range 11–57% · 19 analogues · measured class health 84% in 10 yr · 3% held back for the unknown
how we built this number — every step
Measured class rate — health ≈0.1843/yr → 84% in 10 yr84%
Analyst prior · editorial share 33% of the class28%
Pooled · weight 76%35%
Crowd — no liquid market
Reserve 3% · no extremizing (×1.0)35%
Published34%

The class rate is measured from our dated, sourced event library (decade-normalized Poisson — the full table is public at base_rates.json). The variant’s share within its class is the analyst’s editorial call, published so you can audit it. A wider range means thinner precedent. Full recipe: methodology · scored at Reality Check.

The butterfly cascade

How this trigger trickles across markets, left → right — the root shock, its first‑order moves, then the ripple effects. Drag any node; tap a market for its real price history.

Resolution timeline — how this probability is moving

Our model's odds (gold) over time vs the crowd's (Polymarket, blue), from the past toward the 3–10 years horizon. Each dot is a real macro event that nudged the probability — green pushed it up, red pushed it down. Tap a dot for the source. The gold path is an illustrative reconstruction anchored to today's estimate — real dated events, not a live re-estimate history.

loading the timeline…

What it would mean

If this plays out, it is a mixed shock. Rising healthspan lets people work productively into their late 60s and 70s, expanding effective labor supply and softening the fiscal and growth impact of population aging. The trigger decomposes into signed root‑shocks — Global growth ▲ · Labor shortage ▼ · Longevity ▲ · Risk appetite ▲ — which propagate through our causal graph to the markets below.

If it happens — the markets it would move

Biggest moves first. Projected moves are cascade-model priors; hist A–B% = what comparable past events actually did (measured abnormal returns), and model prior · unmeasured marks markets with no analogue backing yet. Tap any market for its price history.

MarketClassProjected move
1Solana SOLon Hyperliquid 📈 chartCrypto▲ +0.3%
hist -14.07–+3.7% · other way -8.72% (n=7)
2Hyperliquid (HYPE) HYPEon HyperliquidCrypto▲ +0.3%
model prior · unmeasured
3MicroStrategy MSTRon Hyperliquid 📈 chartEquity▲ +0.3%
hist -4.98–+9.69% · other way +1.8% (n=11)
4Ether ETHon Hyperliquid 📈 chartCrypto▲ +0.2%
hist -3.6–+2.13% · other way -8.7% (n=8)
5Nasdaq 100 NDXon Hyperliquid 📈 chartIndex▲ +0.2%
hist +0.05–+0.2% · other way +0.76% (n=11)
6Bitcoin BTCon Hyperliquid 📈 chartCrypto▲ +0.2%
hist -2.68–+4.75% · other way -4.66% (n=10)
7Tech sector XLK 📈 chartEquity▲ +0.1%
hist -0.17–+0.5% · other way +0.76% (n=11)

Probable recommendation

If the scenario above plays out, the probable cross‑asset positioning → a scenario‑conditional read, not personalized investment advice
Short
For a common-man portfolio: Mixed for a typical portfolio — the move is more about rotation than direction. Favour the winners over the losers below rather than net exposure.
Also moves (not yet on Hyperliquid): Tech sector +0.1%

Historical precedent — what analogous events actually did

Across 19 analogous events (overlap‑weighted), as abnormal returns — market beta stripped, so it's the event's own effect, not the market backdrop. Shown at 20 days (persistent) and 5 days (immediate); ↺ fades = the two horizons disagree. Confidence = consistency × sample × significance.

Wegovy 2021-06 First mRNA COVID-19 vaccine authorized 2020-12 Casgevy — first CRISPR gene-editing medicine approved 2023-12 mRNA pioneers win the Nobel 2023-10 First genetically-modified pig-to-human heart transplant 2022-01 AlphaFold cracks the protein-folding problem 2020-11 Human Genome Project completed 2003-04 Nasdaq Composite first close above 20000 2024-12 Neuralink implants its first human brain-computer interface 2024-01 LK-99 room-temperature superconductor claim 2023-07 Strong May 2023 jobs report jolts yields higher 2023-06 Nvidia AI-guidance blowout ignites the automation/AI capex wave 2023-05 OpenAI releases GPT-4 2023-03 NIF achieves fusion ignition 2022-12 Bank of England's first post-pandemic rate hike 2021-12 AlphaGo defeats Lee Sedol 2016-03 SpaceX lands an orbital rocket booster 2015-12 Bank of Japan Kuroda QQE 'bazooka' 2013-04 Volcker Saturday Night Special 1979-10
AssetHistory saysAbnormal (20d · 5d)HitnConfidencevs cascade
SOL SOLSHORT-12.5% · 5d -9.6%83%14 0.51⚠ differs
US dollar DXYSHORT-0.4% · 5d -0.4%68%19 0.28·
ETH ETHSHORT-3.8% · 5d -6.0%64%14 0.22⚠ differs
10y yield DGS10LONG+12bp · 5d +4bp62%19 0.19·
Bitcoin BTCLONG+4.7% · 5d -4.7% ↺ fades55%16 0.09✓ matches cascade
High-yield credit HYGSHORT-0.1% · 5d -0.2%57%17 0.09·
NDX NDXLONG+0.1% · 5d -0.4% ↺ fades56%18 0.08✓ matches cascade
MSTR MSTRLONG+9.5% · 5d -1.1% ↺ fades53%18 0.06✓ matches cascade
Volatility VIXLONG+2.3% · 5d -4.2% ↺ fades51%18 0.02·
XLK XLKLONG+0.4% · 5d -0.1% ↺ fades49%18 0.00✓ matches cascade
Gold XAULONG+0.0% · 5d -0.1% ↺ fades49%18 0.00·

Methodology. Probability and impact are anchored to history and scored against what actually happens — wins and losses, in public, at Reality Check. Crowd odds live from Polymarket & Kalshi. By Vikas Singh, Quantitative Strategist. Updated 2026-07-03.